An article in New Space, a journal about space travel, has been retracted because the results it presented weren’t ready for liftoff.
The retraction notice appears as a letter from editor G. Scott Hubbard: Continue reading Failure to launch: “Inaccuracies,” “incomplete and incorrect references” ground space tourist paper
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation.
The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its Anti-Bacterial Activity Against Staphylococcus aureus,” was written by a trio of researchers at the Center for Nanobiotechnology at VIT University in Vellore.
The article, published online in June, purported to find that: Continue reading Pharmaceutical journal retracts antibiotics paper with dodgy data, with an unclear notice
A pair of researchers at the University of Maryland have retracted a paper in Cell Death & Differentiation after it became clear that one of the figures had been duplicated from an earlier paper.
Here’s the notice, dated December 13, 2013, for “INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis,” by Suryakant Niture and Anil Jaiswal: Continue reading Figure duplication kills cell death paper
Nutrition & Metabolism has retracted a 2008 article by a dwindling group of researchers from Pakistan. We’d say it’s the equivalent of punting on first down, expect that’s what the editors probably should have done in the beginning.
As it happens, the journal seems to be guilty of delay of game in this case. As this blog post by Jeffrey Beall notes, allegations that the now-retracted paper was a verbatim copy of another article arose in 2010.
The abstract of the article, which is still available, reads: Continue reading And then there were none: Plagiarism forces retraction of metabolism paper with vanishing authors
Xia Jiahong, an immunology researcher at Huazhong Science and Technology University in Wuhan, China, who had a paper subject to a fascinating Expression of Concern earlier this month, turns out to have had a few other entries in his retraction and correction record recently.
Here’s a retraction in the January 2014 issue of the Journal of Heart and Lung Transplantation, for “Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation,” a paper first published in 2010: Continue reading Immunology researcher with Expression of Concern has cluster of recent retractions, corrections
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Continue reading IRB mishap costs MD Anderson team a paper on prostate cancer
A group of researchers at Emory has retracted a highly regarded paper after being unable to reproduce its key results.
Here’s the notice from Nature Chemical Biology: Continue reading Failure to reproduce leads to retraction of Nature Chemical Biology herbicide paper
Denis de Jesus Lima Guerra, a co-author on 11 chemistry papers that were retracted in 2011 for suspicions of fraud, has lost his position at the Federal University of Mato Grosso (UFMT).
Bernardo Esteves, who was first to report the news, writes (courtesy Google Translate) that the dismissal was Continue reading Brazilian researcher on 11 retracted papers loses academic post
Cancer Science, the journal of the Japanese Cancer Association, has retracted a 2012 article by a group of researchers because, well, it wasn’t clear who made up the group in the first place.
The article, “Antitumor activity of human γδ T cells transducted with CD8 and with T-cell receptors of tumor-specific cytotoxic T lymphocytes,” appeared online in July 2012 and was written, ostensibly, by Takeshi Hanagiri, Yoshiki Shigematsu, Koji Kuroda, Tetsuro Baba, Hironobu Shiota, Yoshinobu Ichiki, Yoshika Nagata, Manabu Yasuda, Tomoko So, Mitsuhiro Takenoyama and Fumihiro Tanaka from the Second Department of Surgery at the University of Occupational and Environmental Health, in Kitakyushu.
The abstract states: Continue reading Dispute with “unlisted author whose claim to authorship could not be solved” topples cancer paper
Dental Materials Journal has retracted three papers by different groups of authors for “violation of our publishing policies and procedures” — which turns out to be a polite way of saying “they wouldn’t pay our fees.”
The articles are: Continue reading A first? Dental journal retracts three papers because authors didn’t pay publication charges